CIK 0001566044
- Non-accelerated filer
- Smaller reporting company
Yarrow Bioscience, Inc.
Sign in to watch- Ticker
- YARW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 453757789
- Phone
- +1 203-433-7577
- Business address
- 470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
- Former names
- VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 94 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 157 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF LEGAL OFFICER AND GC gave up 161 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 1,004 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 93 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 157 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer and GC gave up 161 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 1,004 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Financial Officer acquired 62,500 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 62,500 shares (grant or award)
- 4 Grant or award Chief Legal Officer and GC acquired 62,500 shares (grant or award)
- 4 Grant or award President and CEO acquired 225,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
Page 5 of 17 · 330 filings